GW Henssler & Associates’s Orgenesis Inc. Common Stock ORGS Stock Holding History

GW Henssler & Associates’s Portfolio ORGS Stock Details ORGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,100	Closed	-$54K	–	233
2021 Q3	$54K	Hold	1,100	–	–	﹤0.01%	107
2021 Q2	$56K	Hold	1,100	–	–	﹤0.01%	222
2021 Q1	$63K	Buy	+1,100	New	+$71.7K	﹤0.01%	231
2020 Q4	–	Sell	-1,100	Closed	-$55K	–	230
2020 Q3	$55K	Hold	1,100	–	–	﹤0.01%	213
2020 Q2	$67K	Hold	1,100	–	–	0.01%	192
2020 Q1	$42K	Hold	1,100	–	–	﹤0.01%	189
2019 Q4	$51K	Hold	1,100	–	–	﹤0.01%	203
2019 Q3	$48K	Hold	1,100	–	–	﹤0.01%	199
2019 Q2	$49K	Hold	1,100	–	–	﹤0.01%	201
2019 Q1	$59K	Hold	1,100	–	–	0.01%	201
2018 Q4	$51K	Buy	+1,100	New	+$63.2K	0.01%	121

Other funds holding ORGS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BHB

Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GW Henssler & Associates's ORGS Position: Q4 2021 in Review

GW Henssler & Associates sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2021, closing a stake of 1,100 shares — an estimated $54K sold.

GW Henssler & Associates first reported a position in ORGS in Q4 2018 and held it in 11 quarters. The position peaked at $67K in Q2 2020. 26 funds tracked by Wall St. Rank hold ORGS as of Q4 2021.

GW Henssler & Associates reported no remaining Orgenesis Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
GW Henssler & Associates sold 1,100 Orgenesis Inc. Common Stock shares in Q4 2021, an estimated $54K.
GW Henssler & Associates first reported a position in Orgenesis Inc. Common Stock in Q4 2018 and held it in 11 quarters.
GW Henssler & Associates's Orgenesis Inc. Common Stock position peaked at $67K in Q2 2020.
26 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2021.

Based on GW Henssler & Associates's 13F filing for Q4 2021, filed 28 Jan 2022.